ESR1 and urinary bladder carcinoma: Furthermore, MCs enhance interactions between estrogen receptors (ERs) and CCL2 within tumors, facilitating bladder cancer invasion through the MC–ER–CCL2 axis, which promotes epithelial-mesenchymal transition (EMT) and matrix metalloproteinase (MMP) activity [82].